Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL176260 | 0.78 | GABRA1 (0.42) | GABRA1GABRB2ALDH1A1MEN1MAPT | |
| SCHEMBL7156023 | 0.76 | XDH (0.38) | XDHGABRA1GABRB2ALDH1A1MEN1 | |
| SCHEMBL5454290 | 0.76 | ALDH1A1 (0.31) | ALDH1A1CYP3A4ALOX15TSHR | |
| SCHEMBL5604556 | 0.76 | CYP3A4 (0.35) | ALDH1A1CYP3A4ALOX15TSHRCASP1 | |
| SCHEMBL7190874 | 0.76 | ALDH1A1 (0.31) | ALDH1A1CYP3A4ALOX15TSHR | |
| SCHEMBL2362110 | 0.76 | ALDH1A1 (0.34) | ALDH1A1HPGD | |
| SCHEMBL1515066 | 0.76 | — | — | |
| SCHEMBL11258836 | 0.76 | XDH (0.32) | XDHGABRA1GABRB2ALDH1A1KDM4E | |
| SCHEMBL299415 | 0.74 | SRD5A1 (0.39) | XDHGABRA1GABRB2ALDH1A1MEN1 | |
| SCHEMBL5170085 | 0.74 | ALDH1A1 (0.39) | ALDH1A1MAPTKMT2AKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10756309-B2 | Light-emitting display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-25 | — | — | US | claimed |
| US-20190280250-A1 | LIGHT-EMITTING DISPLAY DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2019-09-12 | — | — | US | claimed |
| CN-110114366-A | Two banks quinolone conjugate and application thereof | 百奥维骨有限责任公司 | 2019-08-09 | — | — | CN | claimed |
| US-10312443-B2 | Method of manufacturing light-emitting display device and light-emitting display device manufactured using the method | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-06-04 | — | — | US | claimed |
| CN-108699044-A | New pyrrolidin derivatives | 豪夫迈·罗氏有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-104871289-B | Use of a composition comprising a surfactant and a hydrophobising agent to avoid pattern collapse when processing patterned materials having a line spacing dimension of 50nm or less | 巴斯夫欧洲公司 | 2017-10-10 | — | — | CN | claimed |
| US-20160343940-A1 | METHOD OF MANUFACTURING LIGHT-EMITTING DISPLAY DEVICE AND LIGHT-EMITTING DISPLAY DEVICE MANUFACTURED USING THE METHOD | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-11-24 | — | — | US | claimed |
| CN-105520941-A | Substituted gamma lactams as therapeutic agents | ALLERGAN INC | 2016-04-27 | — | — | CN | claimed |
| CN-104871289-A | Use of a composition comprising a surfactant and a hydrophobising agent to avoid resistance to pattern collapse when treating patterned materials having a line spacing dimension of 50nm or less | BASF SE | 2015-08-26 | — | — | CN | claimed |
| US-20130216498-A1 | IMIDAZOPYRIDINE DERIVATIVES AS JAK INHIBITORS | ALMIRALL, S.A. (ES) | 2013-08-22 | — | — | US | claimed |
| US-4536318-A | POLYSACCHARIDE, AND COSURFACTANT OF EITHER ALKYLBENZENE SULFONATE,ALKYL GLYCERYL ETHER SULFONATE, ALPHA-OLEFIN SULFONATE OR POLYETHOXYLATE CARBOXYLATE | THE PROCTER & GAMBLE COMPANY (US) | 1985-08-20 | — | — | US | claimed |
| US-4520095-A | STABLE CYAN DYE FOR COLOR DIFFUSION TRANSFER IN SILVER HALIDE EMULSION-CONTAINING FILMS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1985-05-28 | — | — | US | claimed |
| US-4483779-A | Detergent compositions comprising polyglycoside and polyethoxylate surfactants and anionic fluorescer | THE PROCTER & GAMBLE COMPANY (US) | 1984-11-20 | — | — | US | claimed |
| US-4483780-A | Detergent compositions containing polyglycoside and polyethoxylate detergent surfactants | THE PROCTER & GAMBLE COMPANY (US) | 1984-11-20 | — | — | US | claimed |
| EP-0075994-A2 | Detergent compositions containing mixture of alkylpolysaccharide and amine oxide surfactants and fatty acid soap | THE PROCTER & GAMBLE COMPANY (US) | 1983-04-06 | — | — | EP | claimed |
| EP-0075995-A2 | Detergent compositions containing mixtures of alkylpolysaccharide and nonionic surfactants | THE PROCTER & GAMBLE COMPANY (US) | 1983-04-06 | — | — | EP | claimed |
| EP-0075996-A2 | Detergent compositions containing alkylpolysaccharide and nonionic surfactant mixture and anionic optical brightener | THE PROCTER & GAMBLE COMPANY (US) | 1983-04-06 | — | — | EP | claimed |
| EP-0070076-A2 | Foaming dishwashing liquid compositions | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-19 | — | — | EP | claimed |
| EP-0070075-A2 | Foaming dishwashing liquid compositions | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-19 | — | — | EP | claimed |
| EP-0070077-A2 | Light-duty detergent granule composition | THE PROCTER & GAMBLE COMPANY (US) | 1983-01-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130216498-A1 | IMIDAZOPYRIDINE DERIVATIVES AS JAK INHIBITORS | JAK1, JAK2, JAK3 | XDH 992/4885GABRA1 830/4885GABRB2 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.